Wang Hong, Zhang Guangxing, Sui Hong, Liu Yanhua, Park Kinam, Wang Wenping
Department of Pharmaceutics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.
School of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia 750004, China.
Int J Pharm. 2015 Dec 30;496(2):723-31. doi: 10.1016/j.ijpharm.2015.11.018. Epub 2015 Nov 12.
The O/W emulsion method has been widely used for the production of poly (lactide-co-glycolide) (PLGA) microparticles. Recently, a template method has been used to make homogeneous microparticles with predefined size and shape, and shown to be useful in encapsulating different types of active compounds. However, differences between the template method and emulsion method have not been examined. In the current study, PLGA microparticles were prepared by the two methods using glycyrrhetinic acid (GA) as a model drug. The properties of obtained microparticles were characterized and compared on drug distribution, in vitro release, and degradation. An encapsulation efficiency of over 70% and a mean particle size of about 40μm were found for both methods. DSC thermograms and XRPD diffractograms indicated that GA was highly dispersed or in the amorphous state in the matrix of microparticles. The emulsion method produced microparticles of a broad size distribution with a core-shell type structure and many drug-rich domains inside each microparticle. Its drug release and matrix degradation was slow before Day 50 and then accelerated. In contrast, the template method formed microparticles with narrow size distribution and drug distribution without apparent drug-rich domains. The template microparticles with a loading efficiency of 85% exhibited a zero-order release profile for 3 months after the initial burst release of 26.7%, and a steady surface erosion process as well. The same microparticles made by two different methods showed two distinguished drug release profiles. The two different methods can be supplementary with each other in optimization of drug formulation for achieving predetermined drug release patterns.
油包水乳液法已被广泛用于聚(丙交酯-共-乙交酯)(PLGA)微粒的制备。最近,一种模板法被用于制备具有预定尺寸和形状的均匀微粒,并已证明在包封不同类型的活性化合物方面很有用。然而,模板法和乳液法之间的差异尚未得到研究。在当前的研究中,以甘草次酸(GA)作为模型药物,通过这两种方法制备了PLGA微粒。对所得微粒的性质进行了表征,并在药物分布、体外释放和降解方面进行了比较。两种方法均获得了超过70%的包封率和约40μm的平均粒径。差示扫描量热图(DSC)和X射线粉末衍射图(XRPD)表明,GA在微粒基质中高度分散或处于无定形状态。乳液法制备的微粒尺寸分布较宽,具有核壳型结构,每个微粒内部有许多富含药物的区域。其药物释放和基质降解在第50天之前较慢,然后加速。相比之下,模板法形成的微粒尺寸分布窄且药物分布均匀,没有明显的富含药物的区域。负载效率为85%的模板微粒在初始突发释放26.7%后,呈现出3个月的零级释放曲线,并且也是一个稳定的表面侵蚀过程。由两种不同方法制备的相同微粒显示出两种不同的药物释放曲线。这两种不同的方法在优化药物制剂以实现预定的药物释放模式方面可以相互补充。